Global Injectable Dermal Filler Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

Injectable dermal fillers are gel-like substances injected under the skin to restore lost volume, smooth and soften wrinkles or enhance facial contours. Injectable dermal fillers have developed rapidly and are getting closer and closer to perfect products: long-lasting but non-permanent, high tolerance, delicate and natural cosmetic effects, and reversible in the event of adverse surgical outcomes.

According to APO Research, The global Injectable Dermal Filler market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Injectable Dermal Filler is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Injectable Dermal Filler is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Injectable Dermal Filler is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Injectable Dermal Filler is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Injectable Dermal Filler include Allergan, Galderma, LG Life Sciences, Merz, HUGEL, Beijing IMEIK, Medytox, Bloomage BioTechnology and Croma-Pharma GmbH, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Injectable Dermal Filler, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Injectable Dermal Filler, also provides the sales of main regions and countries. Of the upcoming market potential for Injectable Dermal Filler, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Injectable Dermal Filler sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Injectable Dermal Filler market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Injectable Dermal Filler sales, projected growth trends, production technology, application and end-user industry.


Injectable Dermal Filler Segment by Company

Allergan
Galderma
LG Life Sciences
Merz
HUGEL
Beijing IMEIK
Medytox
Bloomage BioTechnology
Croma-Pharma GmbH
Cleviel (Pharma Research Products)
Elravie (Humedix)
Sinclair
Haohai Biological Technology
Q.O.Fill (JW Pharmaceutical)
Teoxane
Suneva Medical

Injectable Dermal Filler Segment by Type

Hyaluronic Acid
Collagen
CaHA
Others

Injectable Dermal Filler Segment by Application

Specialty & Dermatology Clinics
Hospitals
Others

Injectable Dermal Filler Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Dermal Filler market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Injectable Dermal Filler and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Dermal Filler.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Injectable Dermal Filler market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injectable Dermal Filler manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Injectable Dermal Filler in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Injectable Dermal Filler in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Injectable Dermal Filler Market Size, 2020 VS 2024 VS 2031
1.3 Global Injectable Dermal Filler Market Size Estimates and Forecasts (2020-2031)
1.4 Global Injectable Dermal Filler Sales Estimates and Forecasts (2020-2031)
1.5 Global Injectable Dermal Filler Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Injectable Dermal Filler Market Dynamics
2.1 Injectable Dermal Filler Industry Trends
2.2 Injectable Dermal Filler Industry Drivers
2.3 Injectable Dermal Filler Industry Opportunities and Challenges
2.4 Injectable Dermal Filler Industry Restraints
3 Injectable Dermal Filler Market by Manufacturers
3.1 Global Injectable Dermal Filler Revenue by Manufacturers (2020-2025)
3.2 Global Injectable Dermal Filler Sales by Manufacturers (2020-2025)
3.3 Global Injectable Dermal Filler Average Sales Price by Manufacturers (2020-2025)
3.4 Global Injectable Dermal Filler Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Injectable Dermal Filler Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Injectable Dermal Filler Manufacturers, Product Type & Application
3.7 Global Injectable Dermal Filler Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Injectable Dermal Filler Market CR5 and HHI
3.8.2 Global Top 5 and 10 Injectable Dermal Filler Players Market Share by Revenue in 2024
3.8.3 2024 Injectable Dermal Filler Tier 1, Tier 2, and Tier 3
4 Injectable Dermal Filler Market by Type
4.1 Injectable Dermal Filler Type Introduction
4.1.1 Hyaluronic Acid
4.1.2 Collagen
4.1.3 CaHA
4.1.4 Others
4.2 Global Injectable Dermal Filler Sales by Type
4.2.1 Global Injectable Dermal Filler Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Injectable Dermal Filler Sales by Type (2020-2031)
4.2.3 Global Injectable Dermal Filler Sales Market Share by Type (2020-2031)
4.3 Global Injectable Dermal Filler Revenue by Type
4.3.1 Global Injectable Dermal Filler Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Injectable Dermal Filler Revenue by Type (2020-2031)
4.3.3 Global Injectable Dermal Filler Revenue Market Share by Type (2020-2031)
5 Injectable Dermal Filler Market by Application
5.1 Injectable Dermal Filler Application Introduction
5.1.1 Specialty & Dermatology Clinics
5.1.2 Hospitals
5.1.3 Others
5.2 Global Injectable Dermal Filler Sales by Application
5.2.1 Global Injectable Dermal Filler Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Injectable Dermal Filler Sales by Application (2020-2031)
5.2.3 Global Injectable Dermal Filler Sales Market Share by Application (2020-2031)
5.3 Global Injectable Dermal Filler Revenue by Application
5.3.1 Global Injectable Dermal Filler Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Injectable Dermal Filler Revenue by Application (2020-2031)
5.3.3 Global Injectable Dermal Filler Revenue Market Share by Application (2020-2031)
6 Global Injectable Dermal Filler Sales by Region
6.1 Global Injectable Dermal Filler Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Injectable Dermal Filler Sales by Region (2020-2031)
6.2.1 Global Injectable Dermal Filler Sales by Region (2020-2025)
6.2.2 Global Injectable Dermal Filler Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Injectable Dermal Filler Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Injectable Dermal Filler Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Injectable Dermal Filler Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Injectable Dermal Filler Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Injectable Dermal Filler Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Injectable Dermal Filler Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Injectable Dermal Filler Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Injectable Dermal Filler Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Injectable Dermal Filler Revenue by Region
7.1 Global Injectable Dermal Filler Revenue by Region
7.1.1 Global Injectable Dermal Filler Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Injectable Dermal Filler Revenue by Region (2020-2025)
7.1.3 Global Injectable Dermal Filler Revenue by Region (2026-2031)
7.1.4 Global Injectable Dermal Filler Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Injectable Dermal Filler Revenue (2020-2031)
7.2.2 North America Injectable Dermal Filler Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Injectable Dermal Filler Revenue (2020-2031)
7.3.2 Europe Injectable Dermal Filler Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Injectable Dermal Filler Revenue (2020-2031)
7.4.2 Asia-Pacific Injectable Dermal Filler Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Injectable Dermal Filler Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Injectable Dermal Filler Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Allergan
8.1.1 Allergan Comapny Information
8.1.2 Allergan Business Overview
8.1.3 Allergan Injectable Dermal Filler Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Allergan Injectable Dermal Filler Product Portfolio
8.1.5 Allergan Recent Developments
8.2 Galderma
8.2.1 Galderma Comapny Information
8.2.2 Galderma Business Overview
8.2.3 Galderma Injectable Dermal Filler Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Galderma Injectable Dermal Filler Product Portfolio
8.2.5 Galderma Recent Developments
8.3 LG Life Sciences
8.3.1 LG Life Sciences Comapny Information
8.3.2 LG Life Sciences Business Overview
8.3.3 LG Life Sciences Injectable Dermal Filler Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 LG Life Sciences Injectable Dermal Filler Product Portfolio
8.3.5 LG Life Sciences Recent Developments
8.4 Merz
8.4.1 Merz Comapny Information
8.4.2 Merz Business Overview
8.4.3 Merz Injectable Dermal Filler Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Merz Injectable Dermal Filler Product Portfolio
8.4.5 Merz Recent Developments
8.5 HUGEL
8.5.1 HUGEL Comapny Information
8.5.2 HUGEL Business Overview
8.5.3 HUGEL Injectable Dermal Filler Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 HUGEL Injectable Dermal Filler Product Portfolio
8.5.5 HUGEL Recent Developments
8.6 Beijing IMEIK
8.6.1 Beijing IMEIK Comapny Information
8.6.2 Beijing IMEIK Business Overview
8.6.3 Beijing IMEIK Injectable Dermal Filler Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Beijing IMEIK Injectable Dermal Filler Product Portfolio
8.6.5 Beijing IMEIK Recent Developments
8.7 Medytox
8.7.1 Medytox Comapny Information
8.7.2 Medytox Business Overview
8.7.3 Medytox Injectable Dermal Filler Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Medytox Injectable Dermal Filler Product Portfolio
8.7.5 Medytox Recent Developments
8.8 Bloomage BioTechnology
8.8.1 Bloomage BioTechnology Comapny Information
8.8.2 Bloomage BioTechnology Business Overview
8.8.3 Bloomage BioTechnology Injectable Dermal Filler Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Bloomage BioTechnology Injectable Dermal Filler Product Portfolio
8.8.5 Bloomage BioTechnology Recent Developments
8.9 Croma-Pharma GmbH
8.9.1 Croma-Pharma GmbH Comapny Information
8.9.2 Croma-Pharma GmbH Business Overview
8.9.3 Croma-Pharma GmbH Injectable Dermal Filler Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Croma-Pharma GmbH Injectable Dermal Filler Product Portfolio
8.9.5 Croma-Pharma GmbH Recent Developments
8.10 Cleviel (Pharma Research Products)
8.10.1 Cleviel (Pharma Research Products) Comapny Information
8.10.2 Cleviel (Pharma Research Products) Business Overview
8.10.3 Cleviel (Pharma Research Products) Injectable Dermal Filler Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Cleviel (Pharma Research Products) Injectable Dermal Filler Product Portfolio
8.10.5 Cleviel (Pharma Research Products) Recent Developments
8.11 Elravie (Humedix)
8.11.1 Elravie (Humedix) Comapny Information
8.11.2 Elravie (Humedix) Business Overview
8.11.3 Elravie (Humedix) Injectable Dermal Filler Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Elravie (Humedix) Injectable Dermal Filler Product Portfolio
8.11.5 Elravie (Humedix) Recent Developments
8.12 Sinclair
8.12.1 Sinclair Comapny Information
8.12.2 Sinclair Business Overview
8.12.3 Sinclair Injectable Dermal Filler Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Sinclair Injectable Dermal Filler Product Portfolio
8.12.5 Sinclair Recent Developments
8.13 Haohai Biological Technology
8.13.1 Haohai Biological Technology Comapny Information
8.13.2 Haohai Biological Technology Business Overview
8.13.3 Haohai Biological Technology Injectable Dermal Filler Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Haohai Biological Technology Injectable Dermal Filler Product Portfolio
8.13.5 Haohai Biological Technology Recent Developments
8.14 Q.O.Fill (JW Pharmaceutical)
8.14.1 Q.O.Fill (JW Pharmaceutical) Comapny Information
8.14.2 Q.O.Fill (JW Pharmaceutical) Business Overview
8.14.3 Q.O.Fill (JW Pharmaceutical) Injectable Dermal Filler Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Q.O.Fill (JW Pharmaceutical) Injectable Dermal Filler Product Portfolio
8.14.5 Q.O.Fill (JW Pharmaceutical) Recent Developments
8.15 Teoxane
8.15.1 Teoxane Comapny Information
8.15.2 Teoxane Business Overview
8.15.3 Teoxane Injectable Dermal Filler Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 Teoxane Injectable Dermal Filler Product Portfolio
8.15.5 Teoxane Recent Developments
8.16 Suneva Medical
8.16.1 Suneva Medical Comapny Information
8.16.2 Suneva Medical Business Overview
8.16.3 Suneva Medical Injectable Dermal Filler Sales, Price, Revenue and Gross Margin (2020-2025)
8.16.4 Suneva Medical Injectable Dermal Filler Product Portfolio
8.16.5 Suneva Medical Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Injectable Dermal Filler Value Chain Analysis
9.1.1 Injectable Dermal Filler Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Injectable Dermal Filler Production Mode & Process
9.2 Injectable Dermal Filler Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Injectable Dermal Filler Distributors
9.2.3 Injectable Dermal Filler Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings